The Patient’s Perspective – a column by Reid D’Amico

Cystic fibrosis (CF) is unpredictable. Some days I feel like I can run my fastest personal mile, and on others I feel like I’m staring at the treadmill waiting ... Read more

September 18, 2017September 15, 2017

Allergan and Zenpep Rumors: Researching the Truth

Columns, The Patient's Perspective - a column by Reid D'Amico

In August, Allergan pharmaceuticals announced in a letter to healthcare professionals that it would be restructuring its sales force to align with the “evolving needs of our broad product ... Read more

August 28, 2017August 28, 2017

Importance of Turning to Others for Advice

Columns, The Patient's Perspective - a column by Reid D'Amico

Cystic fibrosis (CF) is horrible. Say it again for the people in the back: It is horrible. To be transparent, I’m writing this article in a bad mood, so ... Read more

July 31, 2017July 31, 2017

Synspira’s Therapy Candidate May Be a Game-Changer for Drug-Resistant Bacteria in CF

Blog, The Patient's Perspective - a column by Reid D'Amico

Chronic pulmonary infections are a hallmark of lung disease in patients with cystic fibrosis. Due to the variability in bacteria that can colonize the lung and the specific antibiotic ... Read more

July 17, 2017July 17, 2017

Kate Marshall, 18, Expresses Concerns Over Healthcare Bill

Columns, The Patient's Perspective - a column by Reid D'Amico

Many of us with pre-existing conditions have been following the news about the future of healthcare in the United States. It really matters to us. Those of us with ... Read more

May 22, 2017May 20, 2017

Kelly Scholarship Gives Those with CF Choices Besides Bachelor’s Degree

Columns, The Patient's Perspective - a column by Reid D'Amico

College is expensive. And when the cost of tuition comes on top of the cost of living with cystic fibrosis, furthering your education can seem daunting. When I was ... Read more

May 8, 2017July 31, 2017

To Treat CF, Understand CF: A Talk with Novoclem Therapeutics

Blog, The Patient's Perspective - a column by Reid D'Amico

Perhaps one of the most exciting parts of being both a patient and a scientist with CF is seeing just how quickly the field is growing. And fortunately, you ... Read more

April 24, 2017April 24, 2017

Tennessee Senate Declares May CF Awareness Month: The Importance of Visibility

Columns, The Patient's Perspective - a column by Reid D'Amico

Last week, I had the opportunity to accompany Vertex Pharmaceuticals as the Tennessee State Senate declared May 2017 Cystic Fibrosis Awareness Month. Sen. Steve Dickerson, R-Nashville, sponsored the resolution, which received ... Read more

April 10, 2017July 31, 2017

Vertex Trial Results and the Importance of CFTR Therapeutic Diversity

Blog, The Patient's Perspective - a column by Reid D'Amico

The CF community was delivered great news the other week: Vertex’s tezacaftor/ivacaftor combination treatment significantly increased lung function (ppFEV1) in patients 12 years or older with certain mutations of the ... Read more

March 20, 2017July 31, 2017

Bad Clinic Visits: It’s Not Just the Numbers

Columns, The Patient's Perspective - a column by Reid D'Amico

No matter how good I feel, there’s always a sense of anxiety and uncertainty when I walk into a routine CF clinic visit. Thoughts swarm my head as my ... Read more